Fig. 3.
Fig. 3. Expression of vβ5 integrin and DF3/MUC1 on OCI-My5 and RPMI 8226 MM cells and on patient MM1 cells. OCI-My5 and RPMI 8226 MM cells and patient MM1 cells (5 × 105/mL) were stained with 1 μL of either vβ5 MoAb (A) or anti-DF3/MUC1 MoAb (B), followed by 1 μL of FITC-conjugated goat (Fab′)2antimouse IgG MoAb, or with 5 μL of FITC-conjugated mouse IgG1 alone (isotype control). The percentage of cells expressing these antigens was determined using indirect immunofluorescence flow cytometric analysis.

Expression of vβ5 integrin and DF3/MUC1 on OCI-My5 and RPMI 8226 MM cells and on patient MM1 cells. OCI-My5 and RPMI 8226 MM cells and patient MM1 cells (5 × 105/mL) were stained with 1 μL of either vβ5 MoAb (A) or anti-DF3/MUC1 MoAb (B), followed by 1 μL of FITC-conjugated goat (Fab′)2antimouse IgG MoAb, or with 5 μL of FITC-conjugated mouse IgG1 alone (isotype control). The percentage of cells expressing these antigens was determined using indirect immunofluorescence flow cytometric analysis.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal